Microneedle Drug Delivery Systems Global Market Report 2023: Increase Research and Demand for Vaccination Processes Bolsters Growth
Global Microneedle Drug Delivery Systems Market
Dublin, March 24, 2023 (GLOBE NEWSWIRE) -- The "Microneedle Drug Delivery Systems Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
The global microneedle drug delivery systems market grew from $3.62 billion in 2022 to $4.07 billion in 2023 at a compound annual growth rate (CAGR) of 12.4%. The microneedle drug delivery systems market is expected to grow to $7.84 billion in 2027 at a CAGR of 17.8%.
North America was the largest region in the microneedles drug delivery systems market in 2022. Europe was the second-largest region in the microneedles drug delivery systems market. The regions covered in the microneedles drug delivery systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Increasing research and demand for the vaccination process are predicted to drive the microneedle drug delivery systems market growth. Researchers view microneedle as an alternative way to inject vaccines where the receiver of the vaccine is expected to not feel any sensation of pain. Microneedle patches vaccine was developed initially for flu and measles; however, the technology is now being used increasingly for delivery of COVID-19 vaccine as well.
For instance, in 2020, The University of Connecticut, Vaxess, and Verndari are using microneedles to deliver viral proteins into the skin, where they induce an immune response. According to a Bloomberg report, more than 3.98 billion doses of vaccine have been administered across 180 countries until July 2021. Increased demand from government and health research and development bodies for microneedle drug delivery technology propels the market for microneedle drug delivery systems going forward.
Biodegradable microneedles drug delivery patches are increasingly used in local therapeutic gene delivery and treatment of chronic diseases. The use of biodegradable microneedles patches helps in easy and fast delivery of genes through targeting the skin as a site for local delivery.
Gene delivery and treatment with these patches are easily accessible and contain fluid and lymph vessels that help the genetic material to act effectively. For instance, in 2020, a group from Terasaki Institute for Biomedical Innovation has recently worked on optimizing the release and performance of the biodegradable patches. Biodegradable microneedles patches offer several advantages in gene delivery such as improved efficacy, fast delivery, customized delivery, and others.
The countries covered in the microneedle drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Scope
Markets Covered:
1) By Technology: Hollow; Porous; Solid; Other Technologies
2) By Application: Drug Delivery; Vaccine Delivery; Other Applications
3) By End-User: Diagnostics Laboratories; Life Sciences; Research Laboratories; Hospitals; Ambulatory Surgical Centers; Other End-Users
Key Attributes:
Report Attribute | Details |
No. of Pages | 200 |
Forecast Period | 2023 - 2027 |
Estimated Market Value (USD) in 2023 | $4.07 billion |
Forecasted Market Value (USD) by 2027 | $7.84 billion |
Compound Annual Growth Rate | 17.8% |
Regions Covered | Global |
Key Topics Covered:
1. Executive Summary
2. Microneedle Drug Delivery Systems Market Characteristics
3. Microneedle Drug Delivery Systems Market Trends And Strategies
4. Microneedle Drug Delivery Systems Market - Macro Economic Scenario
5. Microneedle Drug Delivery Systems Market Size And Growth
6. Microneedle Drug Delivery Systems Market Segmentation
7. Microneedle Drug Delivery Systems Market Regional And Country Analysis
8. Asia-Pacific Microneedle Drug Delivery Systems Market
9. China Microneedle Drug Delivery Systems Market
10. India Microneedle Drug Delivery Systems Market
11. Japan Microneedle Drug Delivery Systems Market
12. Australia Microneedle Drug Delivery Systems Market
13. Indonesia Microneedle Drug Delivery Systems Market
14. South Korea Microneedle Drug Delivery Systems Market
15. Western Europe Microneedle Drug Delivery Systems Market
16. UK Microneedle Drug Delivery Systems Market
17. Germany Microneedle Drug Delivery Systems Market
18. France Microneedle Drug Delivery Systems Market
19. Eastern Europe Microneedle Drug Delivery Systems Market
20. Russia Microneedle Drug Delivery Systems Market
21. North America Microneedle Drug Delivery Systems Market
22. USA Microneedle Drug Delivery Systems Market
23. South America Microneedle Drug Delivery Systems Market
24. Brazil Microneedle Drug Delivery Systems Market
25. Middle East Microneedle Drug Delivery Systems Market
26. Africa Microneedle Drug Delivery Systems Market
27. Microneedle Drug Delivery Systems Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Microneedle Drug Delivery Systems Market
29. Microneedle Drug Delivery Systems Market Future Outlook and Potential Analysis
30. Appendix
A selection of companies mentioned in this report includes
3M
Zosano Pharma
Becton-Dickinson Technologies
Nanopass Technologies
Corium
Valeritas
Microdermics
TheraJect Inc.
LTS Lohmann Therapie-Systeme AG
BioSerenTach (BT)
Sorrento Therapeutics
Debiotech
Raphas Co. Ltd.
QuadMedicine
SNvia
NanoBiosciences
For more information about this report visit https://www.researchandmarkets.com/r/9e4aai
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
